Pure Global AI
NCT06120400Not yet recruiting

Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs

Cardiovascular Effects of a Healthy Dietary Pattern Containing Eggs: a Controlled-feeding Study
Penn State UniversityPhase 3ClinicalTrials.govdrug
Verified
Study focus
Disease/Condition
Cardiovascular Diseases
Drug/Device/Intervention
Whole Egg
Study type
Interventional
Intervention type
drug
Sponsor & location
Primary sponsor
Penn State University
Timeline & enrollment
Phase
Phase 3
Start date
Mar 01, 2024
End date
Dec 01, 2025
Enrollment
65 participants
Primary outcome

LDL-cholesterol change

Summary

This study will examine the effect of a healthy diet containing 2 eggs per day compared to a
 healthy diet containing 3 eggs per week on biomarkers of heart health after 4 weeks.

ICD-10 classifications
Cardiovascular disease, unspecifiedHypertensive heart diseaseOther ill-defined heart diseasesHeart disease, unspecifiedObservation for other suspected cardiovascular diseases
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06120400
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06120400 through Pure Global AI's free database. This Phase 3 trial is sponsored by Penn State University and is currently Not yet recruiting. The study focuses on Cardiovascular Diseases. Target enrollment is 65 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.